Skip to main content
. 2022 Jan 20;11:762233. doi: 10.3389/fonc.2021.762233

Table 1.

Relationship between the expression level of OSbp2 and the clinicopathological parameters of pancreatic cancer patients.

Clinical parameters N OSBP2 expression p-value
High Low
[n (%)] [n (%)]
Sex 0.284
 Male 63 49 (77.8) 14 (22.2)
 Female 37 32 (86.5) 5 (13.5)
Age (years) 0.135
 <60 47 41 (87.2) 6 (12.8)
 ≥60 53 40 (75.5) 13 (24.5)
Nerve invasion 0.011
 Yes 58 52 (89.7) 6 (10.3)
 No 42 29 (69.0) 13 (31.0)
Pathological grading 0.018
 I 12 6 (50.0) 6 (50.0)
 II 78 66 (84.6) 12 (15.4)
 III 10 9 (90.0) 1 (10.0)
AJCC stage 1.000
 I-II 98 79 (80.6) 19 (19.4)
 III–IV 2 2 (100) 0 (0)
Lymph node metastasis 0.427
 Absent (N0) 55 43 (78.2) 12 (21.8)
 Present (N1–3) 45 38 (84.4) 7 (15,6)

All data are expressed as the number of patients (%). P-values were calculated using SPSS 17.0 using a Chi-square test. P-values <0.05 were considered to indicate statistical significance. OSBP2, Oxysterol-binding protein 2; AJCC stage, American cancer Joint Committee stage.